Re-induction with venetoclax in combination with hypomethylating agents (HMAs) versus FLAG-IDA in relapsed or refractory AML.
Year: 2022
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Ian Michael Bouligny, Keri Renee Maher
Institution: VCU Massey Comprehensive Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4286298058